Copyright: ©Author(s) 2026.
World J Hepatol. Oct 27, 2026; 18(10): 124749
Published online Oct 27, 2026. doi: 10.4254/wjh.124749
Published online Oct 27, 2026. doi: 10.4254/wjh.124749
Table 1 Baseline characteristics of enrolled patients, n (%) or median (interquartile range) or mean ± SD
| Characteristics | AF (n = 220) | AP (n = 222) | P value |
| Male | 164 (74.5) | 154 (69.4) | 0.226 |
| Age (≥ 60 years) | 105 (47.7) | 121 (54.5) | 0.154 |
| Etiology of cirrhosis | |||
| Hepatitis B | 100 (45.5) | 97 (43.7) | 0.710 |
| Alcohol | 65 (29.5) | 62 (27.9) | 0.707 |
| Autoimmune | 16 (7.3) | 14 (6.3) | 0.686 |
| Schistosomiasis | 7 (3.2) | 11 (5.0) | 0.346 |
| Wilson’s disease1 | 2 (0.9) | 4 (1.8) | 0.685 |
| MASLD | 10 (4.5) | 12 (5.4) | 0.678 |
| Hepatitis C1 | 3 (1.4) | 1 (0.5) | 0.371 |
| Cryptogenic cirrhosis | 17 (7.7) | 21 (9.5) | 0.516 |
| Type of GEV | |||
| EV | 201 (91.4) | 209 (94.1) | 0.259 |
| GV | 205 (93.2) | 198 (89.2) | 0.139 |
| GOV1 | 149 (67.7) | 139 (62.6) | 0.259 |
| GOV2 | 23 (10.5) | 30 (13.5) | 0.322 |
| GOV3 | 14 (6.4) | 16 (7.2) | 0.724 |
| IGV1 | 17 (7.7) | 13 (5.9) | 0.434 |
| IGV21 | 2 (0.9) | 0 (0.0) | 0.247 |
| Child-Pugh class | |||
| A | 141 (64.1) | 139 (62.6) | 0.747 |
| B + C | 79 (35.9) | 83 (37.7) | |
| HVPG (≥ 12 mmHg)2 | 86 (51.5) | 101 (56.7) | 0.329 |
| Diabetes | 65 (29.3) | 58 (26.1) | 0.423 |
| Hypertension | 53 (23.9) | 58 (26.1) | 0.622 |
| Portal vein thrombosis | 46 (20.7) | 51 (23.0) | 0.600 |
| Ascites | 141 (63.5) | 150 (67.6) | 0.441 |
| BMI (kg/m2) | 22.25 (20.53, 24.28) | 22.09 (20.28, 24.52) | 0.831 |
| ALT (U/L)3 | 25.5 (19.0, 34.8) | 27.0 (20.0, 36.3) | 0.414 |
| AST (U/L)3 | 34.0 (28.0, 45.8) | 36.0 (30.0, 46.0) | 0.205 |
| Albumin (g/L) | 37.9 ± 5.1 | 37.7 ± 4.9 | 0.593 |
| Total bilirubin (μmol/L)3 | 20.5 (13.3, 27.8) | 18.1 (14.3, 25.1) | 0.754 |
| PT (second)3 | 14.9 (14.0, 15.8) | 14.7 (14.1, 15.8) | 0.608 |
| WBC count (109/L)3 | 3.0 (2.3, 4.2) | 3.3 (2.4, 4.6) | 0.134 |
| Neutrophil count (109/L)3 | 1.8 (1.3, 2.6) | 1.9 (1.4, 2.7) | 0.623 |
| Hemoglobin (g/dL)3 | 10.5 ± 2.4 | 10.7 ± 2.3 | 0.202 |
| Platelet count (109/L)3 | 66.0 (43.0, 103.8) | 69.0 (44.0, 123.8) | 0.300 |
- Citation: Xue M, Zhong J, Zhu JN, Wu J, Zhong DD, Zhu CP, Chen Y, Wang LL, Hong YP, Wei W. Prophylactic antibiotics confer no advantage in elective endoscopic treatment for cirrhotic patients with gastroesophageal variceal bleeding history. World J Hepatol 2026; 18(10): 124749
- URL: https://www.wjgnet.com/1948-5182/full/v18/i10/124749.htm
- DOI: https://dx.doi.org/10.4254/wjh.124749